NCT01960010 - A Safety and Efficacy Study of MIM-D3 Ophthalmic Solution for the Treatment of Dry Eye | Biotech Hunter

Enrollment

403

Participants

Timeline

Start Date

October 31, 2013

Primary Completion Date

August 31, 2014

Study Completion Date

August 31, 2014

Conditions

Dry Eye Syndromes

Interventions

DRUG

MIM-D3 Ophthalmic Solution

1% MIM-D3 dosed BID

DRUG

Vehicle

Vehicle dosed BID

Trial Locations (5)

MIM-725 Investigational Site, Memphis

MIM-725 Investigational Site, Waterbury

MIM-725 Investigational Site, Lewiston

MIM-725 Investigational Site, Andover

MIM-725 Investigational Site, Quincy